HealthEquity (NASDAQ:HQY) Stock Price Expected to Rise, Barrington Research Analyst Says

HealthEquity (NASDAQ:HQY) had its price target increased by equities researchers at Barrington Research from $105.00 to $120.00 in a research report issued on Monday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Barrington Research’s price target would indicate a potential upside of 18.35% from the company’s previous close.

Other equities research analysts also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. JMP Securities reaffirmed a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. BTIG Research boosted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Finally, Bank of America boosted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and an average target price of $108.38.

HealthEquity Trading Down 0.3 %

HQY opened at $101.39 on Monday. HealthEquity has a 1-year low of $62.10 and a 1-year high of $105.82. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.85 billion, a P/E ratio of 84.49, a price-to-earnings-growth ratio of 1.59 and a beta of 0.55. The company has a fifty day moving average price of $90.61 and a two-hundred day moving average price of $83.02.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.50 by $0.16. The company had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. Analysts predict that HealthEquity will post 2.27 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Frank Corvino sold 1,039 shares of the stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,536 shares of company stock valued at $884,517. Company insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Institutional investors and hedge funds have recently made changes to their positions in the business. Wasatch Advisors LP boosted its position in HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after buying an additional 483,269 shares during the period. Mackenzie Financial Corp lifted its position in shares of HealthEquity by 16.0% in the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after purchasing an additional 325,906 shares during the period. Generate Investment Management Ltd purchased a new stake in shares of HealthEquity in the 2nd quarter worth about $24,184,000. Vaughan Nelson Investment Management L.P. lifted its position in shares of HealthEquity by 36.7% in the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares during the period. Finally, Thrivent Financial for Lutherans lifted its position in shares of HealthEquity by 924.2% in the 2nd quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock worth $18,983,000 after purchasing an additional 198,718 shares during the period. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.